Antimicrobial agents and urinary tract infections

L Issakhanian, P Behzadi - Current pharmaceutical design, 2019 - ingentaconnect.com
Urinary Tract Infections (UTIs); second-ranking infectious diseases are regarded as a
significant global health care problem. The UTIs annually cost tens of millions of dollars for …
被引用次数：77 相关文章

Antimicrobial agents and urinary tract infections

L Issakhanian, P Behzadi - Current Pharmaceutical Design, 2019 - elibrary.ru
Urinary Tract Infections (UTIs); second-ranking infectious diseases are regarded as a
significant global health care problem. The UTIs annually cost tens of millions of dollars for …

Antimicrobial Agents and Urinary Tract Infections

L Issakhanian, P Behzadi - Current pharmaceutical …, 2019 - pubmed.ncbi.nlm.nih.gov
Urinary Tract Infections (UTIs); second-ranking infectious diseases are regarded as a
significant global health care problem. The UTIs annually cost tens of millions of dollars for …

Antimicrobial Agents and Urinary Tract Infections.

L Issakhanian, P Behzadi - Current Pharmaceutical Design, 2019 - europepmc.org
Urinary Tract Infections (UTIs); second-ranking infectious diseases are regarded as a
significant global health care problem. The UTIs annually cost tens of millions of dollars for …

Antimicrobial Agents and Urinary Tract Infections

L Issakhanian, P Behzadi - Current Pharmaceutical Design, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title/>< jats: p> Urinary Tract Infections (UTIs); second-ranking
infectious diseases are regarded as a significant global health care problem. The UTIs …

Antimicrobial agents and Urinary Tract Infections.

L Issakhanian, P Behzadi - 2019 - cabidigitallibrary.org
Abstract Urinary Tract Infections (UTIs); second-ranking infectious diseases are regarded as
a significant global health care problem. The UTIs annually cost tens of millions of dollars for …